Schonfeld Strategic Advisors LLC Allogene Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.23 - $4.38 $38,338 - $75,300
17,192 New
17,192 $40,000
Q4 2023

Feb 14, 2024
BUY
$2.28 - $3.5 $80,484 - $123,550
35,300 New
35,300 $113,000
Q2 2023

Aug 14, 2023
BUY
$4.53 - $6.74 $463,351 - $689,400
102,285 New
102,285 $508,000
Q4 2022

Feb 14, 2023
SELL
$5.62 - $11.11 $783,377 - $1.55 Million
-139,391 Reduced 52.82%
124,500 $783,000
Q3 2022

Nov 14, 2022
BUY
$10.32 - $17.28 $1.5 Million - $2.51 Million
145,491 Added 122.88%
263,891 $2.85 Million
Q2 2022

Aug 15, 2022
BUY
$6.78 - $12.28 $257,640 - $466,640
38,000 Added 47.26%
118,400 $1.35 Million
Q1 2022

May 16, 2022
BUY
$7.65 - $15.29 $615,060 - $1.23 Million
80,400 New
80,400 $732,000
Q4 2021

Feb 14, 2022
SELL
$13.13 - $24.52 $531,765 - $993,060
-40,500 Closed
0 $0
Q3 2021

Nov 16, 2021
SELL
$21.01 - $27.64 $1.34 Million - $1.76 Million
-63,779 Reduced 61.16%
40,500 $1.04 Million
Q2 2021

Aug 16, 2021
BUY
$23.49 - $35.8 $2.45 Million - $3.73 Million
104,279 New
104,279 $2.72 Million
Q1 2019

May 15, 2019
SELL
$24.82 - $32.54 $248,200 - $325,400
-10,000 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$22.5 - $33.3 $225,000 - $333,000
10,000 New
10,000 $269,000

Others Institutions Holding ALLO

# of Institutions
165
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $279M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email